Fakta om udbudet
EU-nr
2016/S 024-038168
Offentliggjort
Udbudstype
Tildeling af kontrakt uden forudgående offentliggørelse
Pipettes
Contract award notice
Supplies
Section I: Contracting authority
I.1)
Name, addresses and contact point(s)
Københavns Universitet
Nørregade 10
For the attention of: Caroline Volf
1017 København K
DENMARK
Telephone: +45 35333391
E-mail: caroline.volf@adm.ku.dk
Internet address(es):
General address of the contracting authority: www.oko.ku.dk
I.2)
Type of the contracting authority
Body governed by public law
I.3)
Main activity
Education
I.4)
Contract award on behalf of other contracting authorities
The contracting authority is purchasing on behalf of other contracting authorities: no
Section II: Object of the contract
II.1)
Description
II.1.1)
Title attributed to the contract
Acquisition of an Agilent Bravo to Clinical Proteomics.
II.1.2)
Type of contract and location of works, place of delivery or of performance
Supplies
Purchase
Purchase
NUTS code DK011
II.1.3)
Information about a framework agreement or a dynamic purchasing system (DPS)
II.1.4)
Short description of the contract or purchase(s)
Clinical proteomics, a newly established group at CPR, is led by Professor and Program Director, Matthias Mann — an international expert in proteomics technology. The newly established clinical proteomics group is about to undertake an ambitious new biomedical research programme involving proteomics of blood/plasma for patient phenotyping.
II.1.5)
Common procurement vocabulary (CPV)
38437100
II.1.6)
Information about Government Procurement Agreement (GPA)
The contract is covered by the Government Procurement Agreement (GPA): yes
II.2)
Total final value of contract(s)
II.2.1)
Total final value of contract(s)
Value: 602 769,82 DKK
Excluding VAT
Excluding VAT
Section IV: Procedure
IV.1)
Type of procedure
IV.1.1)
Type of procedure
Award of a contract without prior publication of a contract notice in the Official Journal of the European Union (in the cases listed in Section 2 of Annex D1)
Justification for the award of the contract without prior publication of a contract notice in the Official Journal of the European Union (OJEU):
Directive 2004/18/EC
technical
According to the Directive 2004/18/EC of the European Parliament and of the Council, Article 31.1, point b, the University of Copenhagen believes that the Agilent Bravo is a pipetting robot which enable us a high-throughput processing of clinical samples. We already have established our special plasma proteomic sample preparation workflow on an Agilent Bravo instrument in Munich. This pipetting robot owns unique features like high pipetting accuracy, disposable pipetting tips, the possibility of handling small volumes down to 0,5 μl, it avoids cross-contaminations of the samples (which is crucial to clinical samples), full-automation of our special proteomic workflow (because it contains different kinds of workstations within 1 instrument like a Peltier element,heating/shaking positions, place for more than 1 000 disposable pipetting tips, a gripper, 9 different workplaces). Moreover, it allows us the parallel preparation of 100 samples in a very short time by the compact design and the high processing speed. This instrument also fulfils necessary criteria for a real clinical application. This combination of features is necessary for our clinical proteomic workflow and is unique for a pipetting robot. Moreover, Agilent Bravo offers us a discount of nearly 40 % for this product. We already established our special workflow on an Agilent Bravo instrument in Munich and will transfer this technology now to the Clinical Proteomics group in Copenhagen, which allows us the processing of hundreds of samples in a very reproducible way. We will use the Agilent Bravo pipetting robot on a daily basis for several years. The Agilent Bravo is a pipetting robot which enable us a high-throughput processing of clinical samples. This pipetting robot owns unique features like high pipetting accuracy, disposable pipetting tips, handling of small liquid volumes, no cross-contaminations of samples, automation of our special proteomic workflow, which allow us the processing of clinical samples like plasma, blood and saliva.
Justification for the award of the contract without prior publication of a contract notice in the Official Journal of the European Union (OJEU):
Directive 2004/18/EC
1) Justification for the choice of the negotiated procedure without prior publication of a contract notice in the OJEU in accordance with Directive 2004/18/EC
The works/goods/services can be provided only by a particular tenderer for reasons that are:technical
According to the Directive 2004/18/EC of the European Parliament and of the Council, Article 31.1, point b, the University of Copenhagen believes that the Agilent Bravo is a pipetting robot which enable us a high-throughput processing of clinical samples. We already have established our special plasma proteomic sample preparation workflow on an Agilent Bravo instrument in Munich. This pipetting robot owns unique features like high pipetting accuracy, disposable pipetting tips, the possibility of handling small volumes down to 0,5 μl, it avoids cross-contaminations of the samples (which is crucial to clinical samples), full-automation of our special proteomic workflow (because it contains different kinds of workstations within 1 instrument like a Peltier element,heating/shaking positions, place for more than 1 000 disposable pipetting tips, a gripper, 9 different workplaces). Moreover, it allows us the parallel preparation of 100 samples in a very short time by the compact design and the high processing speed. This instrument also fulfils necessary criteria for a real clinical application. This combination of features is necessary for our clinical proteomic workflow and is unique for a pipetting robot. Moreover, Agilent Bravo offers us a discount of nearly 40 % for this product. We already established our special workflow on an Agilent Bravo instrument in Munich and will transfer this technology now to the Clinical Proteomics group in Copenhagen, which allows us the processing of hundreds of samples in a very reproducible way. We will use the Agilent Bravo pipetting robot on a daily basis for several years. The Agilent Bravo is a pipetting robot which enable us a high-throughput processing of clinical samples. This pipetting robot owns unique features like high pipetting accuracy, disposable pipetting tips, handling of small liquid volumes, no cross-contaminations of samples, automation of our special proteomic workflow, which allow us the processing of clinical samples like plasma, blood and saliva.
IV.2)
Award criteria
IV.2.1)
Award criteria
IV.2.2)
Information about electronic auction
IV.3)
Administrative information
IV.3.1)
File reference number attributed by the contracting authority
043-0181/15-7000
IV.3.2)
Previous publication(s) concerning the same contract
Voluntary ex ante transparency notice
Notice number in the OJEU: 2015/S 250-457752 of 26.12.2015
Section V: Award of contract
V.1)
Date of contract award decision:
2.2.2016
V.2)
Information about offers
V.3)
Name and address of economic operator in favour of whom the contract award decision has been taken
Agilent Technologies
Produktionsvej 42
2600 Glostrup
DENMARK
E-mail: ines.nielsen@agilent.com
Telephone: +45 70137313
V.4)
Information on value of contract
Total final value of the contract:
Value: 602 789,82 DKK
Excluding VAT
Value: 602 789,82 DKK
Excluding VAT
V.5)
Information about subcontracting
The contract is likely to be sub-contracted: no
Section VI: Complementary information
VI.1)
Information about European Union funds
The contract is related to a project and/or programme financed by European Union funds: no
VI.2)
Additional information:
VI.3)
Procedures for appeal
VI.3.1)
Body responsible for appeal procedures
Klagenævnet for Udbud
Dahlerups Pakhus, Langelinie Allé 17
2100 København Ø
DENMARK
E-mail: klfu@erst.dk
Telephone: +45 35291000
Internet address: http://www.klfu.dk
VI.3.2)
Lodging of appeals
VI.3.3)
Service from which information about the lodging of appeals may be obtained
Kokurrence- og Forbrugerstyrelsen
Carl Jacobsens Vej 35
2500 Valby
DENMARK
E-mail: kfst@kfst.dk
Telephone: +45 41715000
Internet address: http://www.kfst.dk
VI.4)
Date of dispatch of this notice:
2.2.2016